ES8203611A1 - An anti-tetanus vaccine - Google Patents

An anti-tetanus vaccine

Info

Publication number
ES8203611A1
ES8203611A1 ES502887A ES502887A ES8203611A1 ES 8203611 A1 ES8203611 A1 ES 8203611A1 ES 502887 A ES502887 A ES 502887A ES 502887 A ES502887 A ES 502887A ES 8203611 A1 ES8203611 A1 ES 8203611A1
Authority
ES
Spain
Prior art keywords
tetanus
micro organism
vaccine
make
tetanus vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES502887A
Other languages
Spanish (es)
Other versions
ES502887A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ESPECIALIDADES FARMACEUT CT LA
Original Assignee
ESPECIALIDADES FARMACEUT CT LA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ESPECIALIDADES FARMACEUT CT LA filed Critical ESPECIALIDADES FARMACEUT CT LA
Priority to ES502887A priority Critical patent/ES8203611A1/en
Priority to PT73327A priority patent/PT73327B/en
Priority to GB08137029A priority patent/GB2110085A/en
Priority to FR8123138A priority patent/FR2507079A1/fr
Priority to BE2/59500A priority patent/BE891457A/en
Priority to IT25628/81A priority patent/IT1140348B/en
Priority to GR66877A priority patent/GR77319B/el
Priority to NL8105788A priority patent/NL8105788A/en
Publication of ES502887A0 publication Critical patent/ES502887A0/en
Publication of ES8203611A1 publication Critical patent/ES8203611A1/en
Priority to DE19823219589 priority patent/DE3219589A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

An anti-tetanus vaccine, which may be administered under the tongue, is produced by a process which includes the steps of the purification of the tetanus micro organism to make it active as a vaccine, and the reconstitution of the purified tetanus micro organism with heated twice distilled water so that the micro organism conserves and retains all its immunising qualities, to make it orally absorbable.
ES502887A 1981-06-09 1981-06-09 An anti-tetanus vaccine Expired ES8203611A1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ES502887A ES8203611A1 (en) 1981-06-09 1981-06-09 An anti-tetanus vaccine
PT73327A PT73327B (en) 1981-06-09 1981-07-07 PROCESS FOR THE PREPARATION OF SUBLINGUAL ADMINISTRABLE ANTITETANIC VACCINE
GB08137029A GB2110085A (en) 1981-06-09 1981-12-08 An anti-tetanus vaccine
FR8123138A FR2507079A1 (en) 1981-06-09 1981-12-09
BE2/59500A BE891457A (en) 1981-06-09 1981-12-14 PROCESS FOR OBTAINING SUBLINGUALLY ADMINISTRATIVE ANTITETANIC VACCINE
IT25628/81A IT1140348B (en) 1981-06-09 1981-12-16 PROCEDURE FOR THE PREPARATION OF ANTITETANIC VACCINE
GR66877A GR77319B (en) 1981-06-09 1981-12-21
NL8105788A NL8105788A (en) 1981-06-09 1981-12-22 PROCESS FOR PREPARING AN ANTI-TETANUS VACCINE.
DE19823219589 DE3219589A1 (en) 1981-06-09 1982-05-25 METHOD FOR PRODUCING A TETANUS VACCINE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES502887A ES8203611A1 (en) 1981-06-09 1981-06-09 An anti-tetanus vaccine

Publications (2)

Publication Number Publication Date
ES502887A0 ES502887A0 (en) 1982-04-16
ES8203611A1 true ES8203611A1 (en) 1982-04-16

Family

ID=8482510

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502887A Expired ES8203611A1 (en) 1981-06-09 1981-06-09 An anti-tetanus vaccine

Country Status (9)

Country Link
BE (1) BE891457A (en)
DE (1) DE3219589A1 (en)
ES (1) ES8203611A1 (en)
FR (1) FR2507079A1 (en)
GB (1) GB2110085A (en)
GR (1) GR77319B (en)
IT (1) IT1140348B (en)
NL (1) NL8105788A (en)
PT (1) PT73327B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2851222B1 (en) 2003-02-17 2006-12-01 Mavic Sa SPEED CHANGE CONTROL DEVICE FOR A BIKE AND BIKE EQUIPPED WITH SUCH A DEVICE

Also Published As

Publication number Publication date
NL8105788A (en) 1983-01-03
IT8125628A0 (en) 1981-12-16
GR77319B (en) 1984-09-11
ES502887A0 (en) 1982-04-16
PT73327B (en) 1982-07-30
GB2110085A (en) 1983-06-15
DE3219589A1 (en) 1983-01-13
FR2507079A1 (en) 1982-12-10
BE891457A (en) 1982-03-31
IT1140348B (en) 1986-09-24
PT73327A (en) 1981-08-01

Similar Documents

Publication Publication Date Title
ES487046A1 (en) Purified bacterial proteoglycans, process for their preparation and vaccine containing them.
JPS56128774A (en) New physiologically active substance ebelactone and its preparation
DE3684434D1 (en) METHOD FOR PRODUCING 2-KETO-D-GLUCAR ACID.
JPS5432409A (en) Preparation of ciol and cyclic ether
JPS57206608A (en) Production of gamma-globulin for intravenous injection
ATE40546T1 (en) PRODUCTION OF MANNITOL AND HIGHER MANNOSACCHARIDS.
ES8203611A1 (en) An anti-tetanus vaccine
DE3262622D1 (en) Preparation of a glutaraldehyde precursor
JPS53134876A (en) Production of hydrophilic composite construction
ES406320A1 (en) Process for the preparation of 8,14-cedranoxide
IL89242A (en) Process for producing a recombinant microorganism capable of converting glucose into 2-keto-l-gulonic acid,the microorganism obtained by said process and its use in converting glucose into 2-keto-l-gulonic acid
FR2513123B1 (en)
ES476703A1 (en) Heterovaccine against the trichomonas syndrome, and process for its preparation
ES551926A0 (en) PREPARATION PROCEDURE FOR METOPROLOL AND-OR ETHER 4- (2-METOXYETHYL) -PHENYLGLYCIDYLIC
NZ193807A (en) Improving the response of ruminants to clostridial vaccine by administering tetramisole or levamisole
JPS5290693A (en) Preparation of guanine nucleotide by fermentation
JPS53116357A (en) Preparation of 2,2'-methylene-bis-4,6-dialkylphenol
ES8103733A1 (en) Process of making 6-chloro- alpha -methyl-carbazole-2-acetic acid
JPS5369880A (en) Preparation of lactic acid
JPS51138635A (en) Process for preparation of styrene oxide
JPS52133912A (en) Preparation of butanediol
JPS5417183A (en) Preparation of l-glutamic acid
JPS5271500A (en) Purification of colesterol
JPS5221387A (en) Process for preparing a novel lipase
JPS53105471A (en) Preparation of cyclic ethers

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201